X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1048) 1048
Publication (52) 52
Book Review (5) 5
Book Chapter (4) 4
Conference Proceeding (3) 3
Web Resource (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
vildagliptin (980) 980
index medicus (543) 543
humans (525) 525
diabetes mellitus, type 2 - drug therapy (418) 418
type 2 diabetes (401) 401
male (370) 370
endocrinology & metabolism (337) 337
sitagliptin (309) 309
adamantane - analogs & derivatives (298) 298
female (282) 282
diabetes (280) 280
metformin (249) 249
middle aged (245) 245
hypoglycemic agents - therapeutic use (242) 242
dipeptidyl-peptidase iv inhibitors - therapeutic use (240) 240
pharmacology & pharmacy (215) 215
glucagon-like peptide-1 (203) 203
glucose (200) 200
animals (176) 176
aged (175) 175
diabetes mellitus, type 2 - blood (175) 175
double-blind (173) 173
adamantane - therapeutic use (169) 169
type 2 diabetes mellitus (159) 159
efficacy (155) 155
pyrrolidines - therapeutic use (155) 155
glycemic control (154) 154
nitriles - therapeutic use (153) 153
treatment outcome (152) 152
insulin (151) 151
beta-cell function (147) 147
drug therapy, combination (138) 138
adult (136) 136
hypoglycemic agents (133) 133
dipeptidyl peptidase-4 inhibitor (128) 128
dipeptidyl-peptidase iv inhibitors - adverse effects (127) 127
blood glucose - metabolism (124) 124
diabetes mellitus (123) 123
dipeptidyl-peptidase iv inhibitors - pharmacology (123) 123
hypoglycemic agents - adverse effects (123) 123
blood glucose - drug effects (122) 122
dpp-4 inhibitor (120) 120
safety (114) 114
saxagliptin (113) 113
hypoglycemic agents - administration & dosage (112) 112
diabetes therapy (104) 104
glycated hemoglobin a - metabolism (104) 104
adamantane - adverse effects (102) 102
drug therapy (102) 102
dipeptidyl peptidase-4 inhibitors (101) 101
hypoglycemia (101) 101
improves glycemic control (98) 98
linagliptin (98) 98
dextrose (97) 97
drug-naive patients (95) 95
internal medicine (95) 95
monotherapy (95) 95
care and treatment (93) 93
double-blind method (93) 93
mellitus (91) 91
pyrrolidines - adverse effects (91) 91
hypoglycemic agents - pharmacology (90) 90
nitriles - adverse effects (90) 90
adamantane - pharmacology (89) 89
research (88) 88
dipeptidyl-peptidase iv inhibitors - administration & dosage (86) 86
metformin - therapeutic use (86) 86
pyrrolidines - pharmacology (85) 85
adamantane - administration & dosage (83) 83
glp-1 (82) 82
insulin resistance (82) 82
nitriles - pharmacology (81) 81
rats (81) 81
hyperglycemia (80) 80
pyrrolidines - administration & dosage (79) 79
medicine, general & internal (78) 78
therapy (78) 78
dipeptidyl peptidase-4 (77) 77
analysis (76) 76
medicine & public health (76) 76
type-2 diabetes-mellitus (76) 76
nitriles - administration & dosage (74) 74
management (73) 73
exenatide (70) 70
alogliptin (69) 69
mice (68) 68
dpp-4 inhibitors (67) 67
sitagliptin phosphate (67) 67
clinical trials (66) 66
glucagon (65) 65
diabetes mellitus, type 2 - complications (64) 64
dipeptidyl peptidase 4 - metabolism (64) 64
glycosylated hemoglobin (62) 62
liraglutide (62) 62
blood glucose - analysis (60) 60
endocrine system diseases (60) 60
medicine, research & experimental (60) 60
pharmacokinetics (60) 60
iv inhibitor (58) 58
pioglitazone (58) 58
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (996) 996
German (10) 10
Russian (10) 10
French (9) 9
Japanese (9) 9
Spanish (7) 7
Korean (5) 5
Czech (3) 3
Chinese (2) 2
Hungarian (2) 2
Polish (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 2018, Volume 11, Issue 8, pp. 392 - 394
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 05/2019, Volume 562, pp. 321 - 332
[Display omitted] •The control of the glycemic level among diabetes/T2 patients is very important for their long-term survival and avoiding further... 
Vildagliptin (VD) | DPP-4 | Diabetes/T2 | Db-Db/mice | GLP-1 & GIP | HPMC/EC-DNA-VD nanoparticles | SYSTEM | GLYCEMIC CONTROL | ORIGAMI | SAFETY | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | GLUCAGON-LIKE PEPTIDE-1 | VILDAGLIPTIN | PHARMACOLOGY & PHARMACY | TYPE-2 | Nanoparticles | Analysis | DNA
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2012, Volume 51, Issue 8, pp. 501 - 514
Dipeptidyl peptidase-4 (DPP-4) inhibitors collectively comprise a presently unique form of disease management for persons with type 2 diabetes mellitus. The... 
CD26-antigen-inhibitors | type-2-diabetes-mellitus | linagliptin | sitagliptin | vildagliptin | alogliptin | pharmacokinetics | saxagliptin | Index Medicus
Journal Article
Endocrine Journal, ISSN 0918-8959, 2016
The aim of this 24-week, prospective randomized open-label study was to compare the effects of alogliptin and vildagliptin on glucose control, renal function,... 
Type 2 diabetes | Alogliptin | Vildagliptin
Journal Article
ENDOCRINE JOURNAL, ISSN 0918-8959, 2014, Volume 61, Issue 3, pp. 249 - 256
We previously reported that combination therapy with an α-glucosidase inhibitor (αGI) and a dipeptidyl peptidase-4 (DPP-4) inhibitor increased active... 
Journal Article
Journal of Neurochemistry, ISSN 0022-3042, 06/2015, Volume 133, Issue 5, pp. 700 - 707
Journal Article
Applied Biochemistry and Biotechnology, ISSN 0273-2289, 2018, Volume 188, Issue 1, pp. 165 - 184
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 04/2018, Volume 27, Issue 7, pp. 803 - 806
Journal Article
Journal Article
Journal Article
Diabetologia, ISSN 0012-186X, 8/2018, Volume 61, Issue 8, pp. 1838 - 1848
Journal Article
Journal of Clinical & Translational Endocrinology, ISSN 2214-6237, 12/2019, Volume 18, p. 100206
Remission of Type 2 Diabetes Mellitus (DM) has been observed throughout the last few years, yet factors associated with remission through non-surgical... 
Diabetes Mellitus | Remission | Vildagliptin
Journal Article
Turkish Journal of Endocrinology and Metabolism, ISSN 1301-2193, 2018, Volume 22, Issue 3, pp. 198 - 203
Purpose: Bullous pemphigoid is an autoimmune blistering disorder that commonly develops in elderly subjects who are prone to an increased risk of mortality and... 
Bullous pemphigoid | Diabetes mellitus | Vildagliptin
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2010, Volume 12, Issue 9, pp. 780 - 789
Journal Article